retatrutide phase 2 weight loss results trial retatrutide clinical trial results Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Retatrutide for weight loss: Study

Why Compounded Tirzepatide May Offer Relief Tirzepatidethe active compound in Zepboundis a dual GLP-1 and GIP receptor agonist, meaning it works on two appetite-control pathways simultaneously

Cold Spring Harbor perspectives in biology, 8(8), a005926

Hamedi-Kalajahi F, Zarezadeh M, Mojtahedi SY, Shabbidar S, Fahimi D, Imani H (2021) Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial

A careful escalation schedule gives the body time to adapt while allowing the provider to adjust the pace based on how the patient is responding